Picture of Amdocs logo

DOX — Amdocs Income Statement

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapContrarian

Annual income statement for Amdocs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2022
September 30th
2023
September 30th
2024
September 30th
2025
September 30th
2026
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F6-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalPreliminary
Revenue
Total Revenue4,5774,8885,0054,5334,697
Cost of Revenue
Gross Profit1,6191,7281,7551,722—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,9024,2344,3763,8014,014
Operating Profit675654629732683
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes648636591693636
Provision for Income Taxes
Net Income After Taxes550543496568501
Minority Interest
Net Income Before Extraordinary Items
Net Income550541493565497
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income542532484554—
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.3755.215.65—
Dividends per Share